12/18/2025 | Press release | Distributed by Public on 12/18/2025 16:41
|
FORM 4
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|
|||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) | ||
|
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) |
4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Reporting Owner Name / Address | Relationships | |||
| Director | 10% Owner | Officer | Other | |
|
Rankin Aaron Edward Frederick 131 SOUTH DEARBORN ST. SUITE 700 CHICAGO, IL 60603 |
X | X | ||
| /s/ Heidi Jonas, Attorney-in-fact for Aaron E.F. Rankin | 12/18/2025 | |
| **Signature of Reporting Person | Date |
| * | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| (1) | The transactions reported in this Form 4 occurred under a 10b5-1 plan adopted by the Reporting Person on August 21, 2025. |
| (2) | The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.99 to $11.47 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| (3) | After giving effect to the transaction reported herein, the total reported in column 5 includes: (1) 1,026 reported restricted stock units ("RSUs") which vest in 1 quarterly installments on March 1, 2026; (2) 5,080 reported RSUs which vest in 5 equal quarterly installments beginning on March 1, 2026; (3) 3,816 reported RSUs which vest in 9 equal quarterly installments beginning on March 1, 2025; and (4) 8,298 reported RSUs, which were granted on May 22, 2025, and will vest on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date or (ii) May 22, 2026, the first anniversary of the grant date. Each RSU represents the contingent right to receive one share of Class A Common Stock of the Issuer and does not expire. |